Your payment is in progress...
  +1 (704) 266-3234

COVID-19 Impact On Global CAR T-Cell Therapy Market Size, Status And Forecast 2020-2026

Published on: Jun 2020 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 97

This report focuses on the global CAR T-Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CAR T-Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Celgene (Juno Therapeutics)
Novartis
Gilead (Kite Pharma)
Pfizer
CARsgen Therapeutics
Autolus Therapeutics
Aurora BioPharma
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Collectis
Allogene Therapeutics
Celyad

Market segment by Type, the product can be split into
Allogeneic
Autologous
Market segment by Application, split into
Hospitals
Cancer Research Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global CAR T-Cell Therapy status, future forecast, growth opportunity, key market and key players.
To present the CAR T-Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of CAR T-Cell Therapy are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CAR T-Cell Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Allogeneic
1.4.3 Autologous
1.5 Market by Application
1.5.1 Global CAR T-Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the CAR T-Cell Therapy Industry
1.6.1.1 CAR T-Cell Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19Õs Impact On Crude Oil and Refined Products
1.6.2 Market Trends and CAR T-Cell Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for CAR T-Cell Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 CAR T-Cell Therapy Market Perspective (2015-2026)
2.2 CAR T-Cell Therapy Growth Trends by Regions
2.2.1 CAR T-Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CAR T-Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 CAR T-Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 PorterÕs Five Forces Analysis
2.3.5 CAR T-Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key CAR T-Cell Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Therapy Players by Market Size
3.1.1 Global Top CAR T-Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CAR T-Cell Therapy Market Concentration Ratio
3.2.1 Global CAR T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Revenue in 2019
3.3 CAR T-Cell Therapy Key Players Head office and Area Served
3.4 Key Players CAR T-Cell Therapy Product Solution and Service
3.5 Date of Enter into CAR T-Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global CAR T-Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2021-2026)

5 CAR T-Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global CAR T-Cell Therapy Market Size by Application (2015-2020)
5.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America CAR T-Cell Therapy Market Size (2015-2020)
6.2 CAR T-Cell Therapy Key Players in North America (2019-2020)
6.3 North America CAR T-Cell Therapy Market Size by Type (2015-2020)
6.4 North America CAR T-Cell Therapy Market Size by Application (2015-2020)

7 Europe
7.1 Europe CAR T-Cell Therapy Market Size (2015-2020)
7.2 CAR T-Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe CAR T-Cell Therapy Market Size by Type (2015-2020)
7.4 Europe CAR T-Cell Therapy Market Size by Application (2015-2020)

8 China
8.1 China CAR T-Cell Therapy Market Size (2015-2020)
8.2 CAR T-Cell Therapy Key Players in China (2019-2020)
8.3 China CAR T-Cell Therapy Market Size by Type (2015-2020)
8.4 China CAR T-Cell Therapy Market Size by Application (2015-2020)

9 Japan
9.1 Japan CAR T-Cell Therapy Market Size (2015-2020)
9.2 CAR T-Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan CAR T-Cell Therapy Market Size by Type (2015-2020)
9.4 Japan CAR T-Cell Therapy Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia CAR T-Cell Therapy Market Size (2015-2020)
10.2 CAR T-Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CAR T-Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia CAR T-Cell Therapy Market Size by Application (2015-2020)

11 India
11.1 India CAR T-Cell Therapy Market Size (2015-2020)
11.2 CAR T-Cell Therapy Key Players in India (2019-2020)
11.3 India CAR T-Cell Therapy Market Size by Type (2015-2020)
11.4 India CAR T-Cell Therapy Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America CAR T-Cell Therapy Market Size (2015-2020)
12.2 CAR T-Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America CAR T-Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America CAR T-Cell Therapy Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Celgene (Juno Therapeutics)
13.1.1 Celgene (Juno Therapeutics) Company Details
13.1.2 Celgene (Juno Therapeutics) Business Overview and Its Total Revenue
13.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Introduction
13.1.4 Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2015-2020))
13.1.5 Celgene (Juno Therapeutics) Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis CAR T-Cell Therapy Introduction
13.2.4 Novartis Revenue in CAR T-Cell Therapy Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Gilead (Kite Pharma)
13.3.1 Gilead (Kite Pharma) Company Details
13.3.2 Gilead (Kite Pharma) Business Overview and Its Total Revenue
13.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Introduction
13.3.4 Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2015-2020)
13.3.5 Gilead (Kite Pharma) Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview and Its Total Revenue
13.4.3 Pfizer CAR T-Cell Therapy Introduction
13.4.4 Pfizer Revenue in CAR T-Cell Therapy Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 CARsgen Therapeutics
13.5.1 CARsgen Therapeutics Company Details
13.5.2 CARsgen Therapeutics Business Overview and Its Total Revenue
13.5.3 CARsgen Therapeutics CAR T-Cell Therapy Introduction
13.5.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020)
13.5.5 CARsgen Therapeutics Recent Development
13.6 Autolus Therapeutics
13.6.1 Autolus Therapeutics Company Details
13.6.2 Autolus Therapeutics Business Overview and Its Total Revenue
13.6.3 Autolus Therapeutics CAR T-Cell Therapy Introduction
13.6.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020)
13.6.5 Autolus Therapeutics Recent Development
13.7 Aurora BioPharma
13.7.1 Aurora BioPharma Company Details
13.7.2 Aurora BioPharma Business Overview and Its Total Revenue
13.7.3 Aurora BioPharma CAR T-Cell Therapy Introduction
13.7.4 Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2015-2020)
13.7.5 Aurora BioPharma Recent Development
13.8 Sorrento Therapeutics
13.8.1 Sorrento Therapeutics Company Details
13.8.2 Sorrento Therapeutics Business Overview and Its Total Revenue
13.8.3 Sorrento Therapeutics CAR T-Cell Therapy Introduction
13.8.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020)
13.8.5 Sorrento Therapeutics Recent Development
13.9 Mustang Bio
13.9.1 Mustang Bio Company Details
13.9.2 Mustang Bio Business Overview and Its Total Revenue
13.9.3 Mustang Bio CAR T-Cell Therapy Introduction
13.9.4 Mustang Bio Revenue in CAR T-Cell Therapy Business (2015-2020)
13.9.5 Mustang Bio Recent Development
13.10 Bluebird Bio
13.10.1 Bluebird Bio Company Details
13.10.2 Bluebird Bio Business Overview and Its Total Revenue
13.10.3 Bluebird Bio CAR T-Cell Therapy Introduction
13.10.4 Bluebird Bio Revenue in CAR T-Cell Therapy Business (2015-2020)
13.10.5 Bluebird Bio Recent Development
13.11 Collectis
10.11.1 Collectis Company Details
10.11.2 Collectis Business Overview and Its Total Revenue
10.11.3 Collectis CAR T-Cell Therapy Introduction
10.11.4 Collectis Revenue in CAR T-Cell Therapy Business (2015-2020)
10.11.5 Collectis Recent Development
13.12 Allogene Therapeutics
10.12.1 Allogene Therapeutics Company Details
10.12.2 Allogene Therapeutics Business Overview and Its Total Revenue
10.12.3 Allogene Therapeutics CAR T-Cell Therapy Introduction
10.12.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020)
10.12.5 Allogene Therapeutics Recent Development
13.13 Celyad
10.13.1 Celyad Company Details
10.13.2 Celyad Business Overview and Its Total Revenue
10.13.3 Celyad CAR T-Cell Therapy Introduction
10.13.4 Celyad Revenue in CAR T-Cell Therapy Business (2015-2020)
10.13.5 Celyad Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. CAR T-Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by CAR T-Cell Therapy Revenue
Table 3. Ranking of Global Top CAR T-Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CAR T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Allogeneic
Table 6. Key Players of Autologous
Table 7. COVID-19 Impact Global Market: (Four CAR T-Cell Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for CAR T-Cell Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for CAR T-Cell Therapy Players to Combat Covid-19 Impact
Table 12. Global CAR T-Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global CAR T-Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global CAR T-Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global CAR T-Cell Therapy Market Share by Regions (2015-2020)
Table 16. Global CAR T-Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global CAR T-Cell Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. CAR T-Cell Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key CAR T-Cell Therapy Players
Table 23. Global CAR T-Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global CAR T-Cell Therapy Market Share by Players (2015-2020)
Table 25. Global Top CAR T-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Therapy as of 2019)
Table 26. Global CAR T-Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players CAR T-Cell Therapy Product Solution and Service
Table 29. Date of Enter into CAR T-Cell Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR T-Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global CAR T-Cell Therapy Market Size Share by Type (2015-2020)
Table 33. Global CAR T-Cell Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global CAR T-Cell Therapy Market Size Share by Application (2015-2020)
Table 35. Global CAR T-Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global CAR T-Cell Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players CAR T-Cell Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players CAR T-Cell Therapy Market Share (2019-2020)
Table 39. North America CAR T-Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America CAR T-Cell Therapy Market Share by Type (2015-2020)
Table 41. North America CAR T-Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America CAR T-Cell Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players CAR T-Cell Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players CAR T-Cell Therapy Market Share (2019-2020)
Table 45. Europe CAR T-Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe CAR T-Cell Therapy Market Share by Type (2015-2020)
Table 47. Europe CAR T-Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe CAR T-Cell Therapy Market Share by Application (2015-2020)
Table 49. China Key Players CAR T-Cell Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players CAR T-Cell Therapy Market Share (2019-2020)
Table 51. China CAR T-Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China CAR T-Cell Therapy Market Share by Type (2015-2020)
Table 53. China CAR T-Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China CAR T-Cell Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players CAR T-Cell Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players CAR T-Cell Therapy Market Share (2019-2020)
Table 57. Japan CAR T-Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan CAR T-Cell Therapy Market Share by Type (2015-2020)
Table 59. Japan CAR T-Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan CAR T-Cell Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players CAR T-Cell Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players CAR T-Cell Therapy Market Share (2019-2020)
Table 63. Southeast Asia CAR T-Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia CAR T-Cell Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia CAR T-Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia CAR T-Cell Therapy Market Share by Application (2015-2020)
Table 67. India Key Players CAR T-Cell Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players CAR T-Cell Therapy Market Share (2019-2020)
Table 69. India CAR T-Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India CAR T-Cell Therapy Market Share by Type (2015-2020)
Table 71. India CAR T-Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India CAR T-Cell Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players CAR T-Cell Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players CAR T-Cell Therapy Market Share (2019-2020)
Table 75. Central & South America CAR T-Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America CAR T-Cell Therapy Market Share by Type (2015-2020)
Table 77. Central & South America CAR T-Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America CAR T-Cell Therapy Market Share by Application (2015-2020)
Table 79. Celgene (Juno Therapeutics) Company Details
Table 80. Celgene (Juno Therapeutics) Business Overview
Table 81. Celgene (Juno Therapeutics) Product
Table 82. Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 83. Celgene (Juno Therapeutics) Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Gilead (Kite Pharma) Company Details
Table 90. Gilead (Kite Pharma) Business Overview
Table 91. Gilead (Kite Pharma) Product
Table 92. Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 93. Gilead (Kite Pharma) Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. CARsgen Therapeutics Company Details
Table 100. CARsgen Therapeutics Business Overview
Table 101. CARsgen Therapeutics Product
Table 102. CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 103. CARsgen Therapeutics Recent Development
Table 104. Autolus Therapeutics Company Details
Table 105. Autolus Therapeutics Business Overview
Table 106. Autolus Therapeutics Product
Table 107. Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 108. Autolus Therapeutics Recent Development
Table 109. Aurora BioPharma Company Details
Table 110. Aurora BioPharma Business Overview
Table 111. Aurora BioPharma Product
Table 112. Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 113. Aurora BioPharma Recent Development
Table 114. Sorrento Therapeutics Business Overview
Table 115. Sorrento Therapeutics Product
Table 116. Sorrento Therapeutics Company Details
Table 117. Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 118. Sorrento Therapeutics Recent Development
Table 119. Mustang Bio Company Details
Table 120. Mustang Bio Business Overview
Table 121. Mustang Bio Product
Table 122. Mustang Bio Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 123. Mustang Bio Recent Development
Table 124. Bluebird Bio Company Details
Table 125. Bluebird Bio Business Overview
Table 126. Bluebird Bio Product
Table 127. Bluebird Bio Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 128. Bluebird Bio Recent Development
Table 129. Collectis Company Details
Table 130. Collectis Business Overview
Table 131. Collectis Product
Table 132. Collectis Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 133. Collectis Recent Development
Table 134. Allogene Therapeutics Company Details
Table 135. Allogene Therapeutics Business Overview
Table 136. Allogene Therapeutics Product
Table 137. Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 138. Allogene Therapeutics Recent Development
Table 139. Celyad Company Details
Table 140. Celyad Business Overview
Table 141. Celyad Product
Table 142. Celyad Revenue in CAR T-Cell Therapy Business (2015-2020) (Million US$)
Table 143. Celyad Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Allogeneic Features
Figure 3. Autologous Features
Figure 4. Global CAR T-Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Cancer Research Centers Case Studies
Figure 7. Others Case Studies
Figure 8. CAR T-Cell Therapy Report Years Considered
Figure 9. Global CAR T-Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global CAR T-Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global CAR T-Cell Therapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global CAR T-Cell Therapy Market Share by Players in 2019
Figure 14. Global Top CAR T-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Therapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by CAR T-Cell Therapy Revenue in 2019
Figure 16. North America CAR T-Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe CAR T-Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China CAR T-Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan CAR T-Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia CAR T-Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India CAR T-Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America CAR T-Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Celgene (Juno Therapeutics) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Celgene (Juno Therapeutics) Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novartis Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 27. Gilead (Kite Pharma) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Gilead (Kite Pharma) Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 31. CARsgen Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 33. Autolus Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 35. Aurora BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Aurora BioPharma Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 37. Sorrento Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 39. Mustang Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mustang Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 41. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Bluebird Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 43. Collectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Collectis Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 45. Allogene Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 47. Celyad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Celyad Revenue Growth Rate in CAR T-Cell Therapy Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.